Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Daniel Ahn's Talks
Daniel Ahn
Mayo Clinic Arizona
Lirafrugratinib FDA approved in BTC
October 1, 2026
Daniel Ahn
Mayo Clinic Arizona
00:00
--:--
CRS/HIPEC IN GEA: PERISCOPE2
October 1, 2026
Share
CRS/HIPEC IN GEA: PERISCOPE2
https://www.medspoke.co/channel_playlist?object_id=785&tap_id=14783
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Daniel Ahn
Mayo Clinic Arizona
role for bispecific PD-1/TGFB in GEA?
October 1, 2026
Why are you reporting this TALK?